Novel antitumor peptide hormones and their effect on signal transduction

G. Kéri, Á Balogh, A. Horváth, I. Mezo, Zs Vadász, Gy Bökönyi, T. Bajor, T. Vántus, I. Teplán, J. Horváth, O. Csuka, R. I. Nicholson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitumor activity on DMBA induced mammary carcinomas in rats without blocking ovarian functions. The direct effect of Folligen and Buserelin has been compared on the human breast cancer cell line MDA-MB-231. Folligen was found to be more effective in inhibiting cell proliferation and significant differences were found in the signal transduction pathways activated by these analogs. Our novel Somatostatin analogs were screened for tyrosine kinase inhibition and for antiproliferative effect on human colon tumor cells and for growth hormone (GH) release inhibition in vitro and in vivo. The analog TT-2-50 was significantly more active inhibiting GH release in superfused rat pituitary cells and in vivo than native Somatostatin and it strongly inhibited tyrosine kinase and proliferation while it stimulated protein kinase C activity.

Original languageEnglish
Pages (from-to)105-110
Number of pages6
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume43
Issue number1-3
DOIs
Publication statusPublished - 1992

Fingerprint

Signal transduction
Peptide Hormones
Somatostatin
Signal Transduction
Gonadotropin-Releasing Hormone
Protein-Tyrosine Kinases
Growth Hormone
Rats
Cells
Buserelin
Breast Neoplasms
9,10-Dimethyl-1,2-benzanthracene
Cell proliferation
Protein Kinase C
Tumors
Colon
Cell Proliferation
Cell Line
folligen
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Novel antitumor peptide hormones and their effect on signal transduction. / Kéri, G.; Balogh, Á; Horváth, A.; Mezo, I.; Vadász, Zs; Bökönyi, Gy; Bajor, T.; Vántus, T.; Teplán, I.; Horváth, J.; Csuka, O.; Nicholson, R. I.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 43, No. 1-3, 1992, p. 105-110.

Research output: Contribution to journalArticle

Kéri, G, Balogh, Á, Horváth, A, Mezo, I, Vadász, Z, Bökönyi, G, Bajor, T, Vántus, T, Teplán, I, Horváth, J, Csuka, O & Nicholson, RI 1992, 'Novel antitumor peptide hormones and their effect on signal transduction', Journal of Steroid Biochemistry and Molecular Biology, vol. 43, no. 1-3, pp. 105-110. https://doi.org/10.1016/0960-0760(92)90193-M
Kéri, G. ; Balogh, Á ; Horváth, A. ; Mezo, I. ; Vadász, Zs ; Bökönyi, Gy ; Bajor, T. ; Vántus, T. ; Teplán, I. ; Horváth, J. ; Csuka, O. ; Nicholson, R. I. / Novel antitumor peptide hormones and their effect on signal transduction. In: Journal of Steroid Biochemistry and Molecular Biology. 1992 ; Vol. 43, No. 1-3. pp. 105-110.
@article{eb9b9d778c0e4356a56524cebfe18567,
title = "Novel antitumor peptide hormones and their effect on signal transduction",
abstract = "A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitumor activity on DMBA induced mammary carcinomas in rats without blocking ovarian functions. The direct effect of Folligen and Buserelin has been compared on the human breast cancer cell line MDA-MB-231. Folligen was found to be more effective in inhibiting cell proliferation and significant differences were found in the signal transduction pathways activated by these analogs. Our novel Somatostatin analogs were screened for tyrosine kinase inhibition and for antiproliferative effect on human colon tumor cells and for growth hormone (GH) release inhibition in vitro and in vivo. The analog TT-2-50 was significantly more active inhibiting GH release in superfused rat pituitary cells and in vivo than native Somatostatin and it strongly inhibited tyrosine kinase and proliferation while it stimulated protein kinase C activity.",
author = "G. K{\'e}ri and {\'A} Balogh and A. Horv{\'a}th and I. Mezo and Zs Vad{\'a}sz and Gy B{\"o}k{\"o}nyi and T. Bajor and T. V{\'a}ntus and I. Tepl{\'a}n and J. Horv{\'a}th and O. Csuka and Nicholson, {R. I.}",
year = "1992",
doi = "10.1016/0960-0760(92)90193-M",
language = "English",
volume = "43",
pages = "105--110",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "1-3",

}

TY - JOUR

T1 - Novel antitumor peptide hormones and their effect on signal transduction

AU - Kéri, G.

AU - Balogh, Á

AU - Horváth, A.

AU - Mezo, I.

AU - Vadász, Zs

AU - Bökönyi, Gy

AU - Bajor, T.

AU - Vántus, T.

AU - Teplán, I.

AU - Horváth, J.

AU - Csuka, O.

AU - Nicholson, R. I.

PY - 1992

Y1 - 1992

N2 - A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitumor activity on DMBA induced mammary carcinomas in rats without blocking ovarian functions. The direct effect of Folligen and Buserelin has been compared on the human breast cancer cell line MDA-MB-231. Folligen was found to be more effective in inhibiting cell proliferation and significant differences were found in the signal transduction pathways activated by these analogs. Our novel Somatostatin analogs were screened for tyrosine kinase inhibition and for antiproliferative effect on human colon tumor cells and for growth hormone (GH) release inhibition in vitro and in vivo. The analog TT-2-50 was significantly more active inhibiting GH release in superfused rat pituitary cells and in vivo than native Somatostatin and it strongly inhibited tyrosine kinase and proliferation while it stimulated protein kinase C activity.

AB - A series of novel gonadotropin releasing hormone (GnRH) and Somatostatin analogs have been developed in our laboratory and were screened for antiproliferative and signal transduction inhibitory effect. Our GnRH analog Folligen, had significant antitumor activity on DMBA induced mammary carcinomas in rats without blocking ovarian functions. The direct effect of Folligen and Buserelin has been compared on the human breast cancer cell line MDA-MB-231. Folligen was found to be more effective in inhibiting cell proliferation and significant differences were found in the signal transduction pathways activated by these analogs. Our novel Somatostatin analogs were screened for tyrosine kinase inhibition and for antiproliferative effect on human colon tumor cells and for growth hormone (GH) release inhibition in vitro and in vivo. The analog TT-2-50 was significantly more active inhibiting GH release in superfused rat pituitary cells and in vivo than native Somatostatin and it strongly inhibited tyrosine kinase and proliferation while it stimulated protein kinase C activity.

UR - http://www.scopus.com/inward/record.url?scp=0026613080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026613080&partnerID=8YFLogxK

U2 - 10.1016/0960-0760(92)90193-M

DO - 10.1016/0960-0760(92)90193-M

M3 - Article

VL - 43

SP - 105

EP - 110

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 1-3

ER -